GL1X · GenesisL1 explorer

MolNFT v1 · #159414 · protein

Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with (S)-mcg-IV-226.

6OOO: “Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with (S)-mcg-IV-226.”. X-ray diffraction, 2 ligands (MXJ, NAG), 3 pockets (best druggability 0.55). MolNFT v1 #159414 on GenesisL1: 3D structure, binding sites…

PDB
6OOO
Type
protein
Length
340 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 LM/HT clade A/E CRF01 GP120
UniProt
A0A0M3KKW9
Ligands
MXJ, NAG
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 LM/HT clade A/E CRF01 GP120protein34016% helix, 37% strandA0A0M3KKW9

Ligands and binding sites

  • MXJ · (3S,5R)-5-amino-N~3~-(4-chloro-3-fluorophenyl)-N~1~-propylpiperidine-1,3-dicarboxamide · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11250.550.8328MXJ
2680.450.8217NAG
3510.340.7915empty

Modifications

Observed in the structure: 10 glycan, 8 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6OOO · Crystal structure of HIV-1 LM/HT Clade A/E CRF01 gp120 core in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.